COLL Q4 2017 Earnings — Collegium Pharmaceutical, Inc. Revenue & Financial Results | Market Cap Arena

COLLCollegium Pharmaceutical, Inc.

$1B

Q4 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$11M+728.4% YoY

Gross Profit

$10M89.9% margin

Operating Income

-$18M-162.9% margin

Net Income

-$17M-161.2% margin

EPS (Diluted)

$-0.53

QoQ Revenue Growth

-9.7%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$13M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$136M

Total Liabilities

$31M

Stockholders' Equity

$104M

Cash & Equivalents

$119M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$11M	$1M	+728.4%
Gross Profit	$10M	$1M	+766.8%
Operating Income	-$18M	-$28M	+36.2%
Net Income	-$17M	-$28M	+36.9%